Secukinumab: Rapid Efficacy in Psoriasis After Primary Failure With Ustekinumab and Adalimumab
Saved in:
Main Authors: | Aline Lissa Okita, Tatiane Benini, Denise Reis Longhi |
---|---|
Format: | article |
Language: | EN |
Published: |
Mattioli1885
2020
|
Subjects: | |
Online Access: | https://doaj.org/article/985fde7fec8c4cf2bc426b7226432f67 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Secukinumab in the treatment of psoriasis: patient selection and perspectives
by: Yang EJ, et al.
Published: (2018) -
A Rare Infectious Complication of a Treatment with Biologics: Disseminated Cutaneous Leishmaniasis Associated with Adalimumab
by: Kerasia-Maria Plachouri, et al.
Published: (2020) -
Clinical evidence of therapy for genital psoriasis by biologic agents
by: Evgeny V. Sokolovskiy, et al.
Published: (2021) -
Efficacy of ustekinumab against infliximab-induced psoriasis and arthritis associated with Crohn’s disease
by: Matsumoto S, et al.
Published: (2018) -
Limited clinical utility of HLA-Cw6 genotyping for outcome prediction in psoriasis patients under ustekinumab therapy: a monocentric, retrospective analysis
by: Anzengruber F, et al.
Published: (2018)